| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 4e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |